The experimental results showed that PAD for treating DS greatly reduced the burden of C. albicans in the palate and denture of the rats, improved inflammation symptoms in the palate, and decreased IL-17 and TNF-17 in the palate tissues of diabetic rats with DS. This evidence concerns the gene IL17A and Dravet syndrome.